1. Home
  2. PTY vs TMDX Comparison

PTY vs TMDX Comparison

Compare PTY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTY
  • TMDX
  • Stock Information
  • Founded
  • PTY 2002
  • TMDX 1998
  • Country
  • PTY United States
  • TMDX United States
  • Employees
  • PTY N/A
  • TMDX N/A
  • Industry
  • PTY Investment Managers
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PTY Finance
  • TMDX Health Care
  • Exchange
  • PTY Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • PTY 2.5B
  • TMDX 4.8B
  • IPO Year
  • PTY N/A
  • TMDX 2019
  • Fundamental
  • Price
  • PTY $13.78
  • TMDX $115.68
  • Analyst Decision
  • PTY
  • TMDX Buy
  • Analyst Count
  • PTY 0
  • TMDX 9
  • Target Price
  • PTY N/A
  • TMDX $129.88
  • AVG Volume (30 Days)
  • PTY 550.4K
  • TMDX 909.2K
  • Earning Date
  • PTY 01-01-0001
  • TMDX 07-30-2025
  • Dividend Yield
  • PTY 9.65%
  • TMDX N/A
  • EPS Growth
  • PTY N/A
  • TMDX N/A
  • EPS
  • PTY N/A
  • TMDX 1.41
  • Revenue
  • PTY N/A
  • TMDX $488,227,000.00
  • Revenue This Year
  • PTY N/A
  • TMDX $34.07
  • Revenue Next Year
  • PTY N/A
  • TMDX $20.76
  • P/E Ratio
  • PTY N/A
  • TMDX $82.00
  • Revenue Growth
  • PTY N/A
  • TMDX 64.43
  • 52 Week Low
  • PTY $11.92
  • TMDX $55.00
  • 52 Week High
  • PTY $14.88
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • PTY 52.12
  • TMDX 38.66
  • Support Level
  • PTY $13.75
  • TMDX $109.59
  • Resistance Level
  • PTY $13.95
  • TMDX $127.97
  • Average True Range (ATR)
  • PTY 0.07
  • TMDX 5.57
  • MACD
  • PTY -0.00
  • TMDX -2.35
  • Stochastic Oscillator
  • PTY 54.85
  • TMDX 22.52

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: